References
| Author (yr) | Title | Citation | Isolate |
|---|---|---|---|
| Joao (2020) | Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial. | Lancet HIV | PR HIV1 group M: 388 RT HIV1 group M: 404 IN HIV1 group M: 439 |